🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/08/2015 35,14 35,87 34,21 34,32 -3,54% 4,72% 950.600
19/08/2015 35,76 36,48 34,94 35,58 -0,31% 4,31% 1.156.700
18/08/2015 36,40 36,67 35,50 35,69 -1,92% 3,21% 903.100
17/08/2015 35,35 36,90 34,99 36,39 +3,00% 5,40% 1.212.200
14/08/2015 34,92 35,95 33,72 35,33 +0,45% 6,39% 1.259.300
13/08/2015 34,72 35,94 34,01 35,17 +1,38% 5,56% 1.389.300
12/08/2015 33,21 34,95 32,51 34,69 +3,49% 7,35% 1.182.600
11/08/2015 33,24 34,38 32,77 33,52 -0,50% 4,84% 1.169.200
10/08/2015 32,29 34,05 32,01 33,69 +3,79% 6,32% 1.758.300
07/08/2015 33,94 34,20 30,84 32,46 -6,27% 9,90% 2.263.900
06/08/2015 32,99 35,00 32,04 34,63 +5,81% 8,97% 1.753.800
05/08/2015 33,00 33,84 32,28 32,73 -0,06% 4,73% 1.094.900
04/08/2015 33,50 33,83 32,43 32,75 -2,24% 4,18% 819.300
03/08/2015 32,10 34,52 32,10 33,50 +4,95% 7,54% 1.508.100
31/07/2015 32,00 32,58 31,41 31,92 +0,50% 3,66% 787.100
30/07/2015 31,61 32,02 30,71 31,76 +0,51% 4,14% 699.300
29/07/2015 32,01 32,31 31,12 31,60 -1,34% 3,72% 746.600
28/07/2015 32,24 32,91 31,53 32,03 +0,09% 4,28% 963.100
27/07/2015 32,53 32,54 30,31 32,00 -1,93% 6,86% 1.233.400
24/07/2015 33,18 34,00 32,38 32,63 -2,16% 4,88% 734.900
23/07/2015 33,76 34,35 33,09 33,35 -0,92% 3,73% 766.200
22/07/2015 33,31 34,04 32,58 33,66 -0,12% 4,38% 756.000
21/07/2015 33,73 34,66 33,00 33,70 +0,66% 4,92% 1.449.600
20/07/2015 32,31 34,01 32,31 33,48 +4,20% 5,26% 1.872.800
17/07/2015 31,52 32,56 30,61 32,13 +2,13% 6,19% 928.800
16/07/2015 30,71 31,92 30,61 31,46 +2,38% 4,27% 735.000
15/07/2015 32,23 32,40 30,66 30,73 -3,97% 5,40% 846.900
14/07/2015 30,76 32,27 30,36 32,00 +3,56% 6,21% 1.259.300
13/07/2015 30,08 31,36 30,08 30,90 +2,93% 4,26% 653.800
10/07/2015 29,85 30,14 29,27 30,02 +2,25% 2,91% 507.400